Spruce Biosciences confirms TA-ERT BLA submission on track for Q4 2026
Spruce Biosciences says positive pre-BLA meetings with the FDA support its plan to submit a BLA for TA-ERT in Q4 2026.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.